Mohammed Bosaeed

Consultant, Adult Infectious Diseases/Chairman, Infectious Disease Research Department

A Saudi consultant in adult infectious diseases in the Department of Medicine at King Abdulaziz Medical City in Riyadh, Ministry of National Guard Health Affairs, and Chairman of the Infectious Disease Research Department at King Abdullah International Medical Research Center (KAIMRC). He also serves as Director of Clinical Efficiency in the Clinical Strategy Department at MNGHA and as an assistant professor in the College of Medicine at King Saud bin Abdulaziz University for Health Sciences. He obtained his MBBS from King Abdulaziz University in Jeddah, completed internal medicine residency and adult infectious diseases fellowship training at King Abdulaziz Medical City, and then a one-year clinical fellowship in transplant infectious diseases at the University of Toronto. He was principal investigator of Saudi Arabia's first phase I clinical trial, testing the ChAdOx1 MERS vaccine candidate, and led the favipiravir trial in mild COVID-19. His publications have drawn more than 1,180 citations, with an h-index of 18.